Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

Mileshkin, Linda; N. Moore, Kathleen; H Barnes, Elizabeth; Gebski, Val; Narayan, Kailash; Bradshaw, Nathan; Chen Lee, Yeh; Diamante, Katrina; Fyles, Anthony; Small, William; K. Gaffney, David; Khaw, Pearly; A. Brooks, Susan; S. Thompson, J.; K. Huh, Warner; J. Carlson, Matthew; Mathews, Cara; Rischin, Danny; R. Stockler, Martin; J. Monk, Bradley

doi:10.1200/jco.2021.39.15_suppl.lba3

Public

Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).

Published in Journal of Clinical Oncology • Jun 16, 2021

Authors:

Linda Mileshkin

Kathleen N. Moore

Elizabeth H Barnes

Abstract

LBA3 Background: Cervical cancer is a common cause of cancer-related death among women worldwide. Standard treatment for locally advanced disease is chemoradiation. However, a significant percentage of women still relapse and die from the development of distant metastatic disease. OUTBACK was design...

Subject

Medicine

Cervical cancer

Carboplatin

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!